PRESS RELEASE published on 07/29/2025 at 20:16, 8 months 7 days ago Inside Information / Other news releases Poxel provides update on negotiations with creditors, announces reorganization proceedings & corporate governance change with trading suspension. Press release details Lyon Court filing for insolvency & governance impact Governance Creditors Reorganization Trading Suspension Poxel
PRESS RELEASE published on 07/29/2025 at 20:16, 8 months 7 days ago Informations privilégiées / Autres communiqués Poxel annonce dépôt requête redressement judiciaire, changement gouvernance, suspension cotation. Négociations créanciers et transition opérationnelle en cours Gouvernance Créanciers Transition Redressement Judiciaire Poxel
BRIEF published on 07/08/2025 at 18:51, 8 months 28 days ago Informations sur le capital et les droits de vote de Poxel Droits De Vote Capital Social Actions AMF Poxel
BRIEF published on 07/08/2025 at 18:51, 8 months 28 days ago Information on Poxel's capital and voting rights Share Capital Voting Rights Actions AMF Poxel
PRESS RELEASE published on 07/08/2025 at 18:46, 8 months 28 days ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Poxel communique le nombre total d'actions et de droits de vote composant son capital social conformément à la réglementation AMF Capital Social Actions AMF Réglementé Poxel
BRIEF published on 06/19/2025 at 17:51, 9 months 16 days ago Key Scientific Presentations on Imeglimin at ADA 2025 Diabetes Therapeutic Potential Sumitomo Pharma Imeglimin Scientific Presentations
BRIEF published on 06/19/2025 at 17:51, 9 months 16 days ago Présentations scientifiques clés sur l'Imeglimine à l'ADA 2025 Diabète Présentations Scientifiques Sumitomo Pharma Potentiel Thérapeutique Iméglimine
PRESS RELEASE published on 06/19/2025 at 17:46, 9 months 16 days ago Inside Information / Other news releases Poxel presents new Imeglimin data at ADA 2025 diabetes conference, highlighting therapeutic potential. Key presentations by Japanese experts Diabetes Therapeutic Potential Poxel Imeglimin ADA 2025
PRESS RELEASE published on 06/19/2025 at 17:46, 9 months 16 days ago Informations privilégiées / Autres communiqués Des leaders d'opinion présentent le potentiel thérapeutique de l'Imeglimine lors de l'ADA 2025, le plus grand congrès sur le diabète. POXEL SA annonce cinq présentations à Chicago, Illinois Congrès Diabète Poxel SA Iméglimine ADA 2025
BRIEF published on 06/06/2025 at 19:10, 9 months 29 days ago Poxel : Détails sur le capital social et les droits de vote Droits De Vote Capital Social Actions Informations Réglementées Poxel
Published on 04/02/2026 at 22:00, 3 days 8 hours ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 3 days 11 hours ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 3 days 15 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 3 days 15 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 3 days 15 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 1 day 20 hours ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 2 days 4 hours ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 2 days 12 hours ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 2 days 12 hours ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 2 days 12 hours ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 2 days 11 hours ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 2 days 11 hours ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 2 days 12 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 12 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 2 days 12 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
